Subscribe


Draft approval for Medicines Australia conduct code

ACCC proposes three year authorisation for pharmaceutical code of conduct.

The Australia Competition and Consumer Commission has just announced its draft approval for edition 17 of Medicine Australia’s Code of Conduct.

“The ACCC considers that the Code results in public benefits by providing greater transparency around the relationships between pharmaceutical companies and healthcare professionals,” said ACCC chairman Rod Sims.

However he added that community expectations of disclosure by the industry have increased, saying the ACCC “considers Medicines Australia could go further in ensuring the code meets these expectations now and in the future”.

The Commission has encouraged MA to look for ways to address concerns that have been raised during the ACCC consultation process, including improving the accessibility of reports and the complaints process, as well as “considering disclosure of payments made to individual healthcare professionals”.

MA sought a five year determination, but the draft approval proposes three years of authorisation and during this period the ACCC suggested the organisation could complete work it has already commenced on reviewing the code and make any resulting changes.

Submissions are now being sought on the draft determination.

More information in Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 26 Oct 12

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

20 Feb

Guild Update 20 Feb 18: Workplace resources - GUILD Members may be interested to know ...


20 Feb

Dispensary Corner 20 Feb 18 - SUFFERERS of conditions like irritable bowel syndrome ...


20 Feb

Meds reconciliation - HIGHER accuracy of complex medication reconciliation can ...


20 Feb

Metformin XR recall - APOTEX, in consultation with the TGA, is ...


20 Feb

Arthrem safe - FOLLOWING the NZ Medsafe "potential risk" alert ...


20 Feb

Mundipharma buys Tolmar for Eligard(R) - FOLLOWING several months of comprehensive due diligence ...


20 Feb

Precision medicine - THE future of precision medicine in Australia ...


20 Feb

Dispensing error decriminalisation - NEW legislation to protect community pharmacists in ...


20 Feb

TGA CM advertising debate - BOTH science and civil society organisations have ...


20 Feb

Pharmacy training offers - THE Pharmaceutical Society of Australia (PSA) has ...


19 Feb

Weekly Comment 19 Feb 18: Promoting your personal brand - THIS week's contributor is Heidi Dariz, General ...


19 Feb

Dispensary Corner 19 Feb 18 - PEOPLE can remain very loyal to their ...


19 Feb

Arthrem safety alert - NEW Zealand Medicines and Medical Devices Safety ...


19 Feb

Roche to buy Flatiron - ROCHE has announced it has signed a ...


19 Feb

Gannon slams vaping - AMA president Michael Gannon has highlighted the ...


19 Feb

FDA guidance x seven - THE US Food and Drug Administration (FDA) ...


19 Feb

Potent new flu vaccine - A NEW high dose influenza vaccine will ...


19 Feb

Schulze WA POTY - FORMER PDL chairman and current chairman of ...


19 Feb

WA Guild elections - NOMINATIONS are open for the election of ...


19 Feb

‘Pharmacy first’ says NHS - PARENTS of young children with minor illnesses ...



Show Pharmacy Daily items by month: